Gallotta V - Search Results

1

Enhanced recovery after surgery (ERAS) in gynecology oncology.

Bogani G, Sarpietro G, Ferrandina G, Gallotta V, DI Donato V, Ditto A, Pinelli C, Casarin J, Ghezzi F, Scambia G, Raspagliesi F. Bogani G, et al. Among authors: gallotta v. Eur J Surg Oncol. 2021 May;47(5):952-959. doi: 10.1016/j.ejso.2020.10.030. Epub 2020 Oct 28. Eur J Surg Oncol. 2021. PMID: 33139130 Review.

2

Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report.

Zannoni GF, Gallotta V, Legge F, Tarquini E, Scambia G, Ferrandina G. Zannoni GF, et al. Among authors: gallotta v. Gynecol Oncol. 2004 Jul;94(1):226-8. doi: 10.1016/j.ygyno.2004.03.045. Gynecol Oncol. 2004. PMID: 15262148

3

Cyclooxygenase-2 expression in borderline ovarian tumors.

Ferrandina G, Zannoni GF, Ranelletti FO, Legge F, Gessi M, Salutari V, Gallotta V, Lauriola L, Scambia G. Ferrandina G, et al. Among authors: gallotta v. Gynecol Oncol. 2004 Oct;95(1):46-51. doi: 10.1016/j.ygyno.2004.07.005. Gynecol Oncol. 2004. PMID: 15385109

4

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.

Ferrandina G, Legge F, Martinelli E, Ranelletti FO, Zannoni GF, Lauriola L, Gessi M, Gallotta V, Scambia G. Ferrandina G, et al. Among authors: gallotta v. Br J Cancer. 2005 Jan 31;92(2):271-7. doi: 10.1038/sj.bjc.6602332. Br J Cancer. 2005. PMID: 15655541 Free PMC article.

5

Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.

Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M, Scambia G. Ferrandina G, et al. Among authors: gallotta v. Gynecol Oncol. 2005 Sep;98(3):383-9. doi: 10.1016/j.ygyno.2005.04.024. Gynecol Oncol. 2005. PMID: 15979129

6

Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report.

Ferrandina G, Zannoni GF, Gallotta V, Foti E, Mancuso S, Scambia G. Ferrandina G, et al. Among authors: gallotta v. Gynecol Oncol. 2005 Oct;99(1):215-7. doi: 10.1016/j.ygyno.2005.05.025. Gynecol Oncol. 2005. PMID: 15979130

7

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

Ferrandina G, Zannoni GF, Martinelli E, Paglia A, Gallotta V, Mozzetti S, Scambia G, Ferlini C. Ferrandina G, et al. Among authors: gallotta v. Clin Cancer Res. 2006 May 1;12(9):2774-9. doi: 10.1158/1078-0432.CCR-05-2715. Clin Cancer Res. 2006. PMID: 16675570

8

Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.

Ferrandina G, Carbone A, Zannoni GF, Martinelli E, Testa AC, Gallotta V, De Ninno M, Scambia G. Ferrandina G, et al. Among authors: gallotta v. J Obstet Gynaecol Res. 2007 Feb;33(1):95-9. doi: 10.1111/j.1447-0756.2007.00488.x. J Obstet Gynaecol Res. 2007. PMID: 17212675

9

Laparoendoscopic single-site surgery (LESS) for ovarian cyst enucleation: report of first 3 cases.

Fagotti A, Fanfani F, Marocco F, Rossitto C, Gallotta V, Scambia G. Fagotti A, et al. Among authors: gallotta v. Fertil Steril. 2009 Sep;92(3):1168.e13-1168.e16. doi: 10.1016/j.fertnstert.2009.05.060. Epub 2009 Jul 8. Fertil Steril. 2009. PMID: 19589520 Free article.

10

Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?

Fagotti A, Fanfani F, Vizzielli G, Gallotta V, Ercoli A, Paglia A, Costantini B, Vigliotta M, Scambia G, Ferrandina G. Fagotti A, et al. Among authors: gallotta v. Gynecol Oncol. 2010 Jan;116(1):72-7. doi: 10.1016/j.ygyno.2009.09.015. Epub 2009 Oct 28. Gynecol Oncol. 2010. PMID: 19846211 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters